Cargando…
Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106
We have established variants of DLD‐1 human colon carcinoma and HT‐1080 human fibrosarcoma cells resistant to the new anticancer ribo‐nucleosides, 1‐(3‐C‐ethynyl‐β‐D‐ribo‐pentofuranosyl)‐cytosine (ECyd, TAS‐106) and 1‐(3‐C‐ethynyl‐p‐D‐ribo‐pentofuranosyl)uracil (EUrd). Both variants were shown to ha...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927010/ https://www.ncbi.nlm.nih.gov/pubmed/11985795 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01276.x |